Synthetic small-molecule prohormone convertase 2 inhibitors

Dorota Kowalska, Jin Liu, Jon R. Appel, Akihiko Ozawa, Adel Nefzi, Robert B. Mackin, Richard A. Houghten, Iris Lindberg

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

The proprotein convertases are believed to be responsible for the proteolytic maturation of a large number of peptide hormone precursors. Although potent furin inhibitors have been identified, thus far, no small-molecule prohormone convertase 1/3 or prohormone convertase 2 (PC2) inhibitors have been described. After screening 38 small-molecule positional scanning libraries against recombinant mouse PC2, two promising chemical scaffolds were identified: bicyclic guanidines, and pyrrolidine bis-piperazines. A set of individual compounds was designed from each library and tested against PC2. Pyrrolidine bis-piperazines were irreversible, time-dependent inhibitors of PC2, exhibiting noncompetitive inhibition kinetics; the most potent inhibitor exhibited a K i value for PC2 of 0.54 μM. In contrast, the most potent bicyclic guanidine inhibitor exhibited a K i value of 3.3 μM. Cross-reactivity with other convertases was limited: pyrrolidine bis-piperazines exhibited K i values greater than 25 μM for PC1/3 or furin, whereas the K i values of bicyclic guanidines for these other convertases were more than 15 μM. We conclude that pyrrolidine bis-piperazines and bicyclic guanidines represent promising initial leads for the optimization of therapeutically active PC2 inhibitors. PC2-specific inhibitors may be useful in the pharmacological blockade of PC2-dependent cleavage events, such as glucagon production in the pancreas and ectopic peptide production in small-cell carcinoma, and to study PC2-dependent proteolytic events, such as opioid peptide production.

Original languageEnglish (US)
Pages (from-to)617-625
Number of pages9
JournalMolecular pharmacology
Volume75
Issue number3
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Kowalska, D., Liu, J., Appel, J. R., Ozawa, A., Nefzi, A., Mackin, R. B., Houghten, R. A., & Lindberg, I. (2009). Synthetic small-molecule prohormone convertase 2 inhibitors. Molecular pharmacology, 75(3), 617-625. https://doi.org/10.1124/mol.108.051334